CRWD -31.57AMD -14.48AVGO -59.47TVE.TO 0.45BHP -2.54BBD.B.TO -0.79OWL 0.695
Pfizer Inc (PFE)

NYSE:PFE

Pfizer Inc (PFE)

25.71
+0.37 (1.46%)
as of Jun 4, 2026, 6:38:50 pm Market Open.
579 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
Investor Insights
star iconJun 4, 2026, 12:00 am

This summary was created by AI, based on 31 opinions in the last 12 months.

Pfizer Inc (PFE) is facing significant challenges stemming from a patent cliff, leading to concerns about its drug pipeline and growth prospects in the coming years. Analysts emphasize the company's attractive dividend yield, which hovers around 6-7%, making it appealing for income-focused investors. However, many reviews suggest that the lack of earnings momentum and the need for new blockbuster drugs remain critical issues. Despite a robust pipeline and recent acquisitions, the absence of immediate catalysts for growth has left investors cautious. Overall, while Pfizer provides a decent dividend, its future performance hinges on successful drug development and navigating market sentiment around healthcare reforms.

consensus icon
Consensus
Hold
valuation icon
Valuation
Undervalued
review icon
Similar
NVO
BUY

Pfizer Inc(PFE)

Aug 07, 2003
Likes this company.Valuation is more attractive than what it has been for some time.Generating growth, and very little risk in the stock.
Photo of John ZechnerJohn Zechner
Owned
Unlock Rating
$32.94

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Jul 24, 2003
Good company. Pharmaceutical group is reasonably well priced. Compatition is coming into their core product line.
Photo of Ian AinsworthIan Ainsworth
Owned
Unlock Rating
$32.55

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jul 23, 2003
15/25% earnings growth for the next 3/5 years. High quality.
Photo of Laura WallaceLaura Wallace
Owned
Unlock Rating
$32.93

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Jul 22, 2003
Ethical drug companies are not doing well at this time.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$32.43

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Pfizer Inc(PFE)

Jul 17, 2003
Has the deepest and broadest portfolio of any drug company. 20 drugs under development. Growth may be limited.
Photo of Brad WillockBrad Willock
Owned
Unlock Rating
$32.76

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jul 15, 2003
Has a huge pipeline. PE is at a reasonable level. Good dividends and they are increasing.
Photo of Bob StodgellBob Stodgell
Owned
Unlock Rating
$33.86

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jul 10, 2003
Fair market value is excellant. Investors like drug stocks.
Photo of Ross HealyRoss HealyUnlock Rating
$33.66

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Jul 02, 2003
If you own it, don't let it make new lows on you. Trend is moving higher.
Photo of Bill CarriganBill CarriganUnlock Rating
$34.65

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 19, 2003
All drug companies offer good value right now. Prefers Bristol Myers Squibb.
Photo of Ray SteeleRay SteeleUnlock Rating
$35.60

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jun 13, 2003
US is making progress on a medicare drug plan. 17 X this years earnings and 16 X next. Great pipeline. The stock has underperformed.A lot of free cash flow.
Photo of Laura WallaceLaura WallaceUnlock Rating
$33.08

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 11, 2003
US pharmaceuticals are looking cheaper than they have in some time.
Photo of John ZechnerJohn ZechnerUnlock Rating
$33.28

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Jun 05, 2003
(Was a top pick on Sept 18/02. Up 10%.) Still likes. Thought they would have been higher. Have the most new products coming on line.
Photo of Rob CallanderRob CallanderUnlock Rating
$32.75

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

May 30, 2003
Has been stuck under a major technical resistance of $33/34. Could have a drop.
Photo of Ross HealyRoss HealyUnlock Rating
$31.02

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

May 21, 2003
(Was a top pick on Apr 16/03. Not much change.) Still likes. Continuing to buy at this price.
Photo of Laura WallaceLaura WallaceUnlock Rating
$31.50

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

May 14, 2003
(Was a top pick on Mar 31/03. Up 6.8%) Still likes. Merger with Pharmacia gives them a very powerful potent drug patent.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$33.21

Stock price when the opinion was issued

$25.71

As of Jun 04, 2026. Market Open.

biotechnologypharmaceutical
Showing 766 to 780 of 883 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

PANW -3.74$276.69
GS 51.85$1092.87
AAPL 1.59$311.85
BUG -0.365$36.405
ABBV 6.495$223.625

Today's Top Picks

CRWD -31.57$716.04
AMD -14.48$528.04
AVGO -59.47$419.76
TVE.TO 0.45$14.02
BHP -2.54$88.31

Popular Articles

Latest Sell Signals

AVGO -59.47$419.76
LDOS 1.85$126.2
CME 0$
ULTA -8.555$462.655
MRVL 11.85$313.5

Most Recent Experts

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Bryn Talkington

Bryn Talkington

Requisite Capital Management

Shannon Saccocia, CIO, Boston Private

Shannon Saccocia, CIO, Boston Private

Boston Private

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica